RARE - X Announces Patient Community Data Collection , Sharing , and Platform Enhancements

Researchers and drug developers have been given the go-ahead to expand their work in a bid to improve the understanding of the treatment of rare disease in the US and beyond, according to the American Institute of Allergy and Respiratory Syndrome (ARCS).

Source: prweb.com
Published on 2021-02-23